INTRODUCTION
Keratoacanthoma is an epithelial neoplasm of rapid growth with clinical and
histological features very similar to those of squamous cell carcinoma (SCC). It
was initially described by Hutchinson in 18891. Clinically, keratoacanthoma presents as a single round lesion
with central depression filled with keratin1-4, which looks
like a volcano (Figure 1).
Figure 1 - Typical aspect of keratoacanthoma on the forearm, characterized
by lesions with a central depression.
Figure 1 - Typical aspect of keratoacanthoma on the forearm, characterized
by lesions with a central depression.
Furtado (1962) described the keratoacanthoma as a lesion that starts as a
painless papule, with rapid growth in a few months, followed by maturation,
spontaneous involution, and cicatricial phase. The resulting scar can often be
atrophic, irregular, and unsightly. Neoplasia is prone to recurrence1.
The lesions are generally found in areas of light exposure (Figure 2), especially in lighter skin that presents with
other damages of solar action1-4.
Figura 2 - Typical appearance of a cervical keratoacanthoma.
Figura 2 - Typical appearance of a cervical keratoacanthoma.
Multiple lesions can arise and are associated with previous operations and
trauma. They also develop in syndromes such as Fergunson-Smith and
Witten-Zak2,5, where the multiple neoplasias develop by
genetic inheritance2,5. There are reports of keratoacanthomas in
tattoo sites, with approximately 80% associated with the red pigment6.
Keratoacanthoma has a rapid evolution, reaching its maximum size in approximately
12 weeks2. It tends to spontaneously
involute, without intervention, after a period of four to six months3,4.
Histologically, keratoacanthoma is characterized by a crateriform structure,
filled with keratin and surrounded by symmetrical epidermal horns or spurs
(Figure 3). Intralesional cell
proliferation presents with a majority of well-differentiated epithelial cells.
Mitoses may exist mainly in the basal layer of the epidermis (Figure 4). Rarely, there is deepening of the
lesion beyond the sweat glands. Often, there is associated vascular stroma, with
lymphocytic, histiocytic, neutrophilic, and eosinophilic infiltration7. There is generally a well-delineated
interface between the tumor and underlying subcutaneous tissue (Figure 5). There are also squamous cells
presenting abundant central cytoplasm and absence of significant cellular
atypia8.
Figure 3 - Microscopic image of a keratoacanthoma, characterized by lesions
with a keratin-filled depression and a lateral spur. The interface
between the tumor and underlying subcutaneous tissue is well
delimited (lower magnification 10×).
Figure 3 - Microscopic image of a keratoacanthoma, characterized by lesions
with a keratin-filled depression and a lateral spur. The interface
between the tumor and underlying subcutaneous tissue is well
delimited (lower magnification 10×).
Figura 4 - Keratoacanthoma showing the peripheral proliferation of squamous
cells forming the lateral spur.
Figura 4 - Keratoacanthoma showing the peripheral proliferation of squamous
cells forming the lateral spur.
Figura 5 - Base of the tumor connected with the subcutaneous layer without
an infiltrative pattern and associated with chronic
inflammation.
Figura 5 - Base of the tumor connected with the subcutaneous layer without
an infiltrative pattern and associated with chronic
inflammation.
In initial lesions of SCC, the histological characteristics may be similar to
those of keratoacanthoma. There may be perineural invasion, deep infiltrative
growth, and cellular atypia. These histological features make the clinical
aspects associated with histopathology greatly important for diagnostic
definition. The absence of one of these parameters may make differential
diagnosis impossible7.
Immunohistochemical analyses have been studied for the differential diagnosis. A
specific marker for keratoacanthoma has not yet been identified4,9.
The clinical and histopathological similarities between keratoacanthoma and SCC
make differential diagnosis difficult8.
Distinction between the two neoplasms is extremely important in order to
establish the appropriate treatment, since SCC requires more radical
operations10. If misdiagnoses are
made, correct treatment may be postponed, increasing the chances of recurrence
and metastases of SCC. On clinical examination, the skin surrounding the tumor
is normal, and palpation does not reveal cutaneous infiltration.
Excisional biopsy is the treatment of choice for keratoacanthoma, allowing the
diagnostic definition. Huge variants, such as giant keratoacanthoma (Figure 6), if not managed early, can cause
significant tissue damage, making local reconstruction difficult. Although up to
50% of the cases of keratoacanthoma present spontaneous involution, this process
generates atrophic and hypopigmented scars that are often unaesthetic,
reinforcing the indication of early excision of the lesions2,4.
Figura 6 - A male patient with keratoacanthoma in the inframammary
region.
Figura 6 - A male patient with keratoacanthoma in the inframammary
region.
Surface incisional biopsies, curettage, and shaving are not adequate in the
treatment of keratoacanthoma because it does not allow total evaluation of
histological characteristics. The well-delimited interface between the tumor and
underlying subcutaneous tissue is not examined, and the diagnosis may be
difficult7 and sometimes
impossible11.
Because of several characteristics in common with SCC, early surgical excision is
also necessary to avoid a misdiagnosis, which leads to evolution of a malignant
neoplasm with its complications2. Some
characteristics that aid in distinguishing the lesions are well-delimited
interface between tumor and underlying subcutaneous tissue, squamous cells with
abundant central cytoplasm, and absence of significant cellular atypia8.
OBJECTIVE
The objective of the present study was to evaluate the clinical, morphological,
and epidemiological characteristics of keratoacanthoma.
METHODS
The present observational and retrospective study collected data from 162
patients, corresponding to 173 keratoacanthomas, treated at Hospital Felício
Rocho, Belo Horizonte, MG, from 2005 to 2013.
All patients underwent surgical excision of the tumors. Patients were divided
into two groups. Group 1 consisted of 74 patients, corresponding to 81 lesions,
operated at the Plastic Surgery Clinic of Hospital Felício Rocho. Group 2,
composed of 88 patients, corresponding to 92 keratoacanthomas, underwent
treatment at other clinics of the same hospital. Only the patients in group 1
were followed postoperatively, for at least two years.
Patients diagnosed with keratoacanthoma, based on the anatomopathological
examination of the Department of Pathology of Hospital Felício Rocho, were
included in this study. Patients who had the surgical specimen analyzed by the
same department but underwent surgery in another institution were excluded from
the study. The included reports were used as data source, aiming to determine
sex, age, number of lesions, location, tumor size, and preoperative
diagnosis.
In group 1, tumor recurrence as well as the appearance of new lesions compatible
with the diagnosis, even in a different place far from the initial lesion, was
verified.
Data were entered into Microsoft Office Excel spreadsheet, and graphics were
created using SigmaPlot software version 10.0.
There were no conflicts of interest in this study, and the principles of the
Declaration of Helsinki revised in 2000 and resolution 196/96 of the National
Health Council were followed.
RESULTS
A total of 162 patients were evaluated, with a total of 173 lesions. There were
154 patients presenting with a single keratoacanthoma (95.06%), six (3.70%)
patients had two lesions, one (0.62%) had three lesions, and one (0.62%) had
four lesions.
Of the 162 patients, 92 (56.80%) were male and 70 (43.20%) were female, resulting
in a male/female sex ratio of 1.31 (Figure 7). The ages of the patients ranged from 11 to 96 years, with an
average of 71.23 years.
Figura 7 - Percentage distribution of patients by sex.
Figura 7 - Percentage distribution of patients by sex.
The keratoacanthomas were detected and treated predominantly in the eighth and
ninth decades of life, corresponding to 55.00% of the cases (Figure 8). In two patients, the age was not
mentioned.
Figura 8 - Percentage distribution of patients by age group.
Figura 8 - Percentage distribution of patients by age group.
In eight patients (4.62%), the location of the lesion was not reported.
Seventy-two lesions (41.62%) were located in the upper limbs, 47 (27.17%) in the
face, 29 (16.76%) in the lower limbs, 13 (7.51%) in the trunk, two (1.16%) in
the neck, and two (1.16%) in the scalp (Figure 9).
Figura 9 - Percentage distribution of lesions by location.
Figura 9 - Percentage distribution of lesions by location.
The lesion size ranged from 0.2 cm to 3.5 cm, with an average size of 1.07
cm.
In 13 (7.51%) requests for pathological exams, the diagnostic hypothesis was not
revealed by the physician. In 101 (63.13%) of the 160 diagnostic hypotheses
formulated, the surgeon made a correct diagnosis. In 59 (36.88%) cases,
preoperative diagnoses were erroneous.
Of the 74 patients treated by the plastic surgery team of the Hospital Felício
Rocho, no recurrence of keratoacanthoma was identified during the two-year
follow-up period. Three (6.80%) patients presented with new lesions, but in a
different location from that of the first lesion. One patient (1.35%) presented
with a new lesion at the site of the previous keratoacanthoma 6 months after the
excision, but the new lesion was diagnosed histopathologically as SCC. The first
approach of this patient was performed through the “shaving” technique
(superficial tangential biopsy), which was not recommended as the deep interface
of the tumor was not analyzed.
DISCUSSION
Keratoacanthoma is a rapidly growing skin tumor, presenting histopathological
features that are similar to those of SCC2,4. There are
cases in which the differential diagnosis is controversial4,11. It
is currently described as a benign tumor in the larger part of the
literature2-6,8 but has already been considered a pseudomalignant lesion and even
a variant of SCC4,12.
Clinically, keratoacanthoma is most often manifested as a single, nodular, round,
firm lesion with a central depression filled with keratin2,3,4. At the
clinical examination, in the palpation of its contour, it is perceived that the
tumor does not infiltrate the adjacent skin. The skin is loose from the deep
planes, and the lesion has no infiltrated or swollen margins. In this study,
95.06% of the patients studied presented single keratoacanthomas, since it is in
accordance with the researched literature.
The tumor presents with rapid growth, reaching its definitive size in a few
weeks3. Brenn and McKee4 described an average diameter of 1 cm to 2
cm in those lesions. Kirkham3 enlarged
this average to 1 cm to 2.5 cm. These data are corroborated in the present
study, which found lesions varying from 0.2 cm to 3.5 cm, with an average
diameter of 1.07 cm.
The lesions are located in areas of greater exposure to ultraviolet B (UVB)
radiation, in places where other signs of photoaging are already found2,13,14. According
to Brenn and McKee4, up to 95% of solitary
lesions develop in areas of sun exposure, with predominant appearance on the
face and upper limbs. These data are reinforced by the present study, which
showed 43.64% of keratoacanthomas were in the upper limbs (Figure 10), 28.48% in the face (Figure 11), 17.58% in the lower limbs, 7.88% in the trunk,
1.21% in the neck, and 1.21% on the scalp.
Figura 10 - Keratoacanthoma on the thumb.
Figura 10 - Keratoacanthoma on the thumb.
Figura 11 - A male patient with keratoacanthoma on the lower lip.
Figura 11 - A male patient with keratoacanthoma on the lower lip.
Keratoacanthomas are more commonly found in the men, with a male/female ratio of
up to 3:14. Confirming this
characteristic, data from this study showed that 92 (56.80%) patients were male
and 70 (43.20%) female, resulting in a male/female sex ratio of 1.31.
The incidence of the tumor increases with age3. According to Brenn and McKee4, the majority of patients have ages in the sixth or seventh
decades of life. In this work, the data found in the literature were ratified.
The ages ranged from 11 to 96 years, with an average of 71.23 years. Cases in
the eighth and ninth decades of life prevailed, corresponding to 55.00%.
The latter data were different from the cited literature, probably due to the
change in life expectancy of the population. There are several similarities
between keratoacanthoma and SCC, and it is often difficult to distinguish them
only with clinical or histopathological characteristics. Kirkham3 reported that differential diagnosis was
not so difficult in advanced lesions, when clinical and histopathological
peculiarities are already identified. However, in early lesions, differentiation
may be difficult.
In cases of diagnostic doubts, the aggressive behavior of SCC3,7 indicates that the lesions may be treated as a carcinoma, with
extensive surgical excision4,7. In the present
study, in 63.13% of cases, the keratoacanthoma was found in the diagnostic
hypotheses formulated by the surgeons in the request of an anatomopathological
analysis, and in 36.88% of cases, the hypotheses were erroneous. The data
revealed that, despite the often difficult differential diagnosis, the surgeons
in the study, probably due to a good knowledge of skin tumors, included the
correct diagnosis in the suspected lesions.
Regarding the recurrence of keratoacanthoma, the literature data showed rates of
8%3. In the present study, 74 patients
were followed during the two-year period, and 6.80% presented new lesions, but
in a different location from that of the first lesion. Only one patient
presented, in six months, with a new lesion at the same place as that in the
previous surgical approach. It is important to note that the primary treatment,
in this particular patient, had been performed by shaving, a technique not
recommended for the treatment of keratoacanthoma.
The new lesion was diagnosed histopathologically as SCC, demonstrating that the
differential diagnosis may be difficult and, therefore, it is necessary to
follow-up the treated patients. In shaving, the entire lesion is often not
resected, and differentiation with SCC becomes even more difficult as it does
not allow the tumor to interface with the underlying subcutaneous tissue. In
keratoacanthoma, the subcutaneous tissue is preserved. In SCC, there is an
invasion in the interface of the underlying subcutaneous tissue.
CONCLUSION
Keratoacanthoma is an epithelial neoplasm with characteristics similar to those
of SCC, which often makes clinical diagnosis difficult. Therefore, complete
surgical excision of suspected lesions is necessary for correct diagnosis and
treatment. The surgical technique of choice is excisional biopsy.
In view of the possibility of erroneous diagnosis in the usual techniques of
pathology and the possibility of keratoacanthoma development in other sites,
minimum follow-up of about two years is necessary.
ACKNOWLEDGMENTS
The authors thank Dr. Gil Patrus Mundim Pena for the preparation of the
photomicrographs of the present study.
COLLABORATIONS
LN
|
Analysis and/or interpretation of data; statistical analyses; final
approval of the manuscript; conception and design of the study;
completion of surgeries and/or experiments.
|
JCRRA
|
Analysis and/or interpretation of data; statistical analyses; final
approval of the manuscript; conception and design of the study;
completion of surgeries and/or experiments; writing the manuscript
or critical review of its contents.
|
EHP
|
Analysis and/or interpretation of data; statistical analyses; final
approval of the manuscript; conception and design of the study;
completion of surgeries and/or experiments; writing the manuscript
or critical review of its contents.
|
RPLF
|
Analysis and/or interpretation of data; statistical analyses; final
approval of the manuscript.
|
JSAF
|
Analysis and/or interpretation of data; final approval of the
manuscript; completion of surgeries and/or experiments.
|
NAP
|
Final approval of the manuscript; completion of surgeries and/or
experiments.
|
RLFS
|
Analysis and/or interpretation of data; statistical analyses; final
approval of the manuscript; writing the manuscript or critical
review of its contents.
|
ACMA
|
Final approval of the manuscript; conception and design of the study;
completion of surgeries and/or experiments; writing the manuscript
or critical review of its contents.
|
REFERENCES
1. Furtado TA. Ceratoacantoma e processos afins; estudo clínico,
histopatológico e experimental [Tese]. Belo Horizonte: Faculdade de Ciências
Médicas de Minas Gerais; 1962.
2. Vergilis-Kalner IJ, Kriseman Y, Goldberg LH. Keratoacanthomas:
overview and comparison between Houston and minneapolis experiences. J Drugs
Dermatol. 2010;9(2):117-21.
3. Kirkham N. Tumors and cysts of the epidermis. In: Elder DE,
Elenitsas R, Johnson BL Jr, Murphy GF, eds. Lever's histopathology of the skin.
Philadelphia: Lippincott Williams & Wilkins; 2005. p.
805-51.
4. Brenn T, McKee PH. Tumors of the surface epithelium. In: McKee PH,
Calonje E, Granter SR, ed. McKee's Pathology of the skin. Philadelphia: Elsevier
Mosby; 2005. p. 1153-239.
5. Brongo S, Moccia LS, Nunziata V, D'Andrea F. Keratoacantoma arising
after site injection infection of cosmetic collagen filler. Int J Surg Case Rep.
2013;4(4):429-31. DOI: http://dx.doi.org/10.1016/j.ijscr.2013.01.012
6. Vitiello M, Echeverria B, Romanello P, Abuchar A, Kerdel F. Multiple
eruptive keratoachantomas arising in a tattoo. J Clin Aesthet Dermatol.
2010;3(7):54-5.
7. McKee P, Calonje E, Grantner SR. Pathology of the skin with clinical
correlations. 3th ed. Philadelphia: Elsevier Mosby; 2005.
8. Tan KB, Tan SH, Aw DCW, Jaffar H, Lim TC, Lee SJ, et al. Simulators
os squamous cell carcinoma of the skin: diagnostic challenges on small biopsies
and clinicopathological correlation. J Skin Cancer.
2013;2013:752864.
9. Soddu S, Di Felice E, Cabras S, Castellanos ME, Atzori L, Faa G, et
al. IMP-3 expression in keratoacanthoma and squamous cell carcinomas of the
skin: an immunohistochemical study. Eur J Histochem. 2013;57(6):e6. DOI:
http://dx.doi.org/10.4081/ejh.2013.e6
10. Tas E, Ugur BM, Gul A, Cinar F, Uzun L, Gun BD. A misdiagnosed
keratoacantoma turned out to be a metastatic parotid carcinoma. Acta
Otorhinolaryngol Ital. 2010;30(2):115-7.
11. Elder DE, Elenitsas R, Johnson BL Jr, Murphy GF, eds. Lever's
Histopathology of the Skin. 9th ed. Philadelphia: Lippincott Williams &
Wilkins; 2005.
12. Weedon DD, Malo J, Brooks D, Williamson R. Squamous cell carcinoma
arising in keratoacanthoma: a neglected phenomenon in the elderly. Am J
Dermatopathol. 2010;32(5):423-6. DOI: http://dx.doi.org/10.1097/DAD.0b013e3181c4340a
13. Sazafi MS, Salina H, Asma A, Masir N, Primuharsa Putra SH.
Keratoacanthoma: an unusual nasal mass. Acta Otorhinolaryngol Ital.
2013;33(6):428-30.
14. Muthupalaniappen L, Das S, Md Nor N, Ali SA. Nodular Melanoma
Mimicking Keratoacanthoma: Lessons to learn. Sultan Qaboos Univ Med J.
2012;12(3):360-3. DOI: http://dx.doi.org/10.12816/0003153
1. Sociedade Brasileira de Cirurgia Plástica, São
Paulo, SP, Brazil.
2. Hospital Felício Rocho, Belo Horizonte, MG,
Brazil.
3. Universidade Federal de Minas Gerais, Belo
Horizonte, MG, Brazil.
4. Instituto de Cirurgia Plástica Avançada, Belo
Horizonte, MG, Brazil.
5. Faculdade de Medicina, Universidade de Itaúna,
MG, Belo Horizonte, MG, Brazil.
Corresponding author: Erick Horta
Portugal, Rua Santa Maria de Itabira, 217, Bairro Sion, Belo
Horizonte, MG, Brazil. Zip Code 30310-600. E-mail:
erickhphp@yahoo.com.br
Article received: April 10, 2017.
Article accepted: June 22, 2018.
Conflicts of interest: none.